what is known already: Normal LC function is essential for male development and reproduction. Signs of LC failure, including LC micronodules, are often observed in patients with reproductive disorders. study design, size, participants: In this retrospective study, a panel of markers and factors linked to the differentiation of LCs was investigated in 33 fetal and prepubertal human specimens and in 58 adult testis samples from patients with testicular germ cell tumours, including precursor carcinoma in situ (CIS), infertility or Klinefelter syndrome.
Introduction
Leydig cells (LCs) are essential for male development and reproduction. The LCs function primarily through the secretion of hormones and paracrine factors, including testosterone and insulin-like peptide-3 (INSL3), which orchestrate the virilization of the developing male fetus, testis descent, progression through puberty and the maintenance of reproductive health in adult life.
The LC population in humans may be described as triphasic, with fetal, neonatal and adult LCs, and their sequential appearance corresponds to peaks in circulating testosterone levels during intrauterine development, mini-puberty and young adulthood, respectively (Prince, 2001) . Our knowledge of LC differentiation from tissue stem cells to fully mature LCs with maximal steroidogenic capacity is well characterized in rats. The differentiation of adult rat LCs can be described as four subsequent stages distinguished by function and morphology; adult LCs are derived from stem cells that differentiate to spindle-shaped progenitor LCs, round immature LCs and polygonal mature LCs (Chen et al., 2010) , and similar forms have been described in the human testis (Christensen, 1975; Nistal et al., 1986) . Like other differentiated cells, adult LCs have very little mitotic activity and any renewal in the LC population depends on recruitment from tissue stem cells and/or a LC progenitor pool (Keeney et al., 1990) .
LC function is often attenuated in reproductive disorders, including Klinefelter syndrome, where one of the histological hallmarks is the presence of very large LC clusters (Wikströ m and Dunkel, 2011) . LC dysfunction has also been observed in men with disorders comprised within the testicular dysgenesis syndrome (TDS), such as subfertility, cryptorchidism, hypospadias and testicular germ cell tumours (TGCT) in which disturbed early development of the testis is a key element in the pathogenesis (Skakkebaek et al., 2001; Joensen et al., 2008) . Decreased LC function typically manifests as a decreased testosterone/luteinising hormone (LH) ratio and the presence of LC micronodules in the testis. The number and size of LC micronodules, defined as clusters of LCs .15 cells in a cross-section, increases with the severity of testis dysfunction, as well as with increasing gonadotrophin levels Lardone et al., 2012) . This suggests that testes with low testosterone levels attempt to compensate by increasing the number of LCs. The formation of LC micronodules in patients with TGCTs may be further stimulated by the high levels of human chorionic gonadotrophin (hCG) secreted from a subset of tumours, especially nonseminomas with choriocarcinoma components. Regardless of the tumour type and hCG levels, LC micronodules have been observed in the contralateral testis in 75.2% of patients with testicular cancer (Hoei-Hansen et al., 2003) .
The aetiology of LC micronodules is poorly understood, but they are often observed in patients with high levels of gonadotrophins , which suggests disruption of hypothalamic-pituitary-gonadal (HPG)-axis signalling. This is supported by clinical observations in subfertile men. These men often have low testosterone levels Andersson et al., 2004) and high compensatory levels of gonadotrophins, causing hyperstimulation and thus increased recruitment of cells to the LC population.
Ultrastructural differences between normal LCs and those in micronodules have been suggested to reflect that the latter population is not fully differentiated (Paniagua et al., 1984; Söderströ m, 1986) . This is in line with animal studies showing signs of immaturity in LC hyperplasia induced by high exposure to anti-androgens or genetic ablations of androgen receptor (AR) signalling in conditional knockout mouse models that are characterized by reduced testosterone levels Welsh et al., 2012) .
It remains to be clarified whether or not the LC micronodules observed in humans with reproductive disorders linked to impaired testis development contain poorly differentiated cells, as has been demonstrated for other cell types; early neoplastic germ cells, carcinoma in situ cells (CIS), displaying fetal gonocyte-like features, and visibly undifferentiated Sertoli cells are often seen in men with TGCT or cryptorchidism (Hoei-Hansen et al., 2003; Sonne et al., 2009 ). But our knowledge of markers of human LC differentiation is scarce.
Traditional markers of LC function are predominantly steroidogenic enzymes such as cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1) and 3b-hydroxysteroid dehydrogenase (3b-HSD) (Greco and Payne, 1994) that are expressed by hormonally active LCs. More recently, INSL3 has been proposed as a marker of LC maturity and of gonadotrophin-independent basal LC function (Bay et al., 2006; Ivell et al., 2013) . Additional markers of LC development and differentiation are needed to investigate the characteristics of LCs in testicular dysfunction, and particularly of LCs within micronodules. Among the candidates of such markers are delta-like homolog 1 (DLK1) (Jensen et al., 1999) and chicken ovalbumin upstream promoter transcription factor 2 (COUP-TFII), previously shown to be expressed in a subset of the mouse adult LCs (Jensen et al., 1999; Qin et al., 2008) , but not yet evaluated in human testicular pathologies.
DLK1 (also known as fetal antigen 1, Pref-1, ZOG, pG2) is broadly expressed in fetal tissues, whereas its expression in adulthood is restricted mainly to specific cells in tissues with neuroendocrine properties or a regenerative potential (Floridon et al., 2000) . It is expressed in fetal LCs and in a subset of adult LCs (Jensen et al., 1999) . DLK1 is a paternally imprinted gene that encodes a transmembrane protein with several EGF-like repeats (Jensen et al., 1993) . Many imprinted genes have important impacts on mammalian development, and regulatory roles of DLK1 have been demonstrated in cell-fate decision and terminal differentiation of progenitor cells in various tissues (Abdallah et al., 2004; Waddell et al., 2010; Wang et al., 2010; Chen et al., 2011; Surmacz et al., 2011) . DLK1 is synthesized as a membrane-bound protein where the outer EGF-like repeats can be cleaved off and released to the serum (Jensen et al., 1994) , suggesting dual functions of DLK1. DLK1 knockout mice are fertile, despite a reduced litter size (Moon et al., 2002) . However, the testicular phenotype has not been evaluated.
COUP-TFII is known to affect LC differentiation and in the fetal gonad it is abundantly expressed in interstitial cells and in fetal LCs when they first arise in the testes. Later in gestation down-regulation of COUP-TFII in fetal LCs is considered necessary for proper development of these cells (van den Driesche et al., 2012) . It is also essential for the pubertal transition of progenitor LCs into mature LCs, and the establishment of the mature LC population (Qin et al., 2008) .
In this study, we sought to establish the developmental expression patterns of DLK1, COUP-TFII and the well-known markers of LCs (INSL3 and CYP11A1) and peritubular cells (smooth muscle actin (SMA)) in the human testis. We also examined the expression of these markers in testis tissue from patients with different testicular pathologies, to shed light on the differentiation status of LCs in these disorders. We focused on disorders linked to impaired testis development with prominent LC micronodules, such as male infertility and testicular cancer, where we hypothesize that aberrant LC differentiation may play a role. In addition, we investigated patients with Klinefelter syndrome, which is an example of a genetically determined disorder with the presence of large LC nodules.
Materials and Methods

Tissue collection and preparation
Fetal gonads were obtained from aborted tissue (elective abortions performed at gestational week (GW) 7 -11), or from the autopsy material of miscarried fetuses stored at the pathology department . Infantile, pubertal and morphologically normal adult testis samples were obtained from autopsy specimens collected and stored during a previous project conducted at our department (Giwercman et al., 1991) . Additional morphologically normal adult testis samples were obtained from residual diagnostic biopsies from idiopathic infertile men with normal testis histology. Testicular specimens from patients with carcinoma in situ (CIS) or testicular cancer were obtained at the time of orchidectomy. These samples had a variable histology in the surrounding testis parenchyma, ranging from complete spermatogenesis, various degrees of hypospermatogenesis, CIS and atrophic hyalinised tubules to Sertoli-cell-only (SCO) tubules. Specimens from patients with Klinefelter syndrome were obtained from residual diagnostic biopsies. Following surgical excision, the tissue samples were immediately fixed in formalin or modified Stieve's fixative, dehydrated and embedded in paraffin. Samples for gene expression analysis were snap-frozen and stored at 2808C prior to RNA extraction. Relative gene expression at mRNA level was analysed in 24 adult orchidectomy specimens from patients with CIS, TGCT or LC tumours, including 6 samples with normal LCs, 7 samples with LC micronodules, 5 samples with LC micronodules from testes with an hCG-producing tumour, and 5 samples with severe atrophy of the seminiferous tubules. For expression of all the markers at the protein level, a total of 28 developmental and 31 adult specimens were investigated by immunohistochemistry (IHC), and an additional 5 fetal and 27 adult samples were investigated for DLK1 expression only.
The samples are listed in Table I . Additionally, expression of the proliferation marker KI-67 was investigated in 10 adult and 3 fetal testis samples, and for two of the TGCT samples with atrophy, we investigated 11 pieces of the adjacent tumours for hCG-positive cells by IHC.
Ethical approval
Patients were recruited from Rigshospitalet or Gentofte Hospital, Denmark, and patient material was obtained and handled in accordance with the Helsinki Declaration. The samples of early fetal (GW 7 -11) or infantile tissue, and adult autopsy material were donated and collected for research purposes only. All other samples were obtained for diagnostic or treatment procedures and only leftover material was used in this study. The use of stored and newly collected samples has been approved by the Ethics Committees of Sciences in the Capital Region of Denmark (protocol number: H-2-2009-37). Informed consent from patients was obtained prior to sample collections.
qRT -PCR
Total RNA from frozen samples of representative orchidectomy specimens was isolated with the NucleoSpin RNA II purification kit, as described by the manufacturer (Macherey-Nagel, Germany The testis parenchyma in orchidectomy specimens often contains a mixed pattern of different histologies. In this table, such samples are categorized according to the primary histology of the section investigated. c COUP-TFII was not investigated in samples from Klinefelter patients due to antibody incompatibility with the fixative of these samples.
Human Leydig cells in normal development and TDS 1 mg RNA using a dT20 primer and random hexamers to a final volume of 100 ml. Specific intron-spanning primers targeting each mRNA were designed from Ensembl sequences (www.ensembl.org) and are listed in Table II . qRT -PCR assays were run on a Mx300P platform (Stratagene, TX, USA) using SYBR green (Agilent Technologies, CA, USA) with a reaction volume of 30 ml including 1 ml cDNA. PCR conditions were: 958C for 10 min, 40 cycles of 958C for 30 s, 608C for 1 min, and 728C for 1 min, and then a final cycle of 958C for 1 min, 608C for 30 s, and 958C for 30 s. Changes in gene expression were quantified using the comparative CT method and expression levels were normalized to b2-microglobulin (B2M) to adjust for differences in input RNA, or to CYP11A1 to adjust for LC cellularity.
Immunohistochemistry
The IHC analyses were performed using a standard indirect peroxidase method. Briefly, 4 mm serial sections were deparaffinised and rehydrated. Antigen retrieval was accomplished by microwaving the sections for 15 min in TEG, Citrate or Urea buffer. Afterwards all sections were incubated with 2% non-immune goat serum (Zymed Histostain kit, CA, USA) to minimize cross-reactivity. The sections were incubated overnight with primary antibodies (listed in Table III ) diluted in Tris-buffered saline (TBS). For a negative control, the primary antibody was replaced with TBS. The following day the sections were incubated with biotinylated goat anti-rabbit IgG or goat anti-mouse IgG (Zymed Histostain kit) before a peroxidase-conjugated streptavidin complex (Zymed Histostain kit) was used as a tertiary layer. Visualization was performed with amino ethyl carbasole (Zymed Histostain kit). Washing in TBS was done between each step, except between goat serum and primary antibody. All slides were counterstained with Meyer's haematoxylin.
All sections were scanned on a NanoZoomer HT 2.0 and evaluated using the NDPview software version 1.2.36 (Hamamatsu Photonics, Germany). The numbers of total LCs and DLK1-positive LCs including polygonal, round and plump-spindle-shaped LCs, but not the elongated spindle-shaped cells, which are presumed to be progenitor cells, were calculated as the average of cells counted in three fields of 0.5 mm 2 surface for each of 34 adult samples. The number of samples with no, weak or strong DLK1 expression in the peritubular cells was counted, and also the number of samples with normal, slightly enlarged or enlarged peritubular layers was counted. Three of the orchidectomy samples had clearly defined areas of distinguishable histology. In these samples both areas were counted separately and included in the analyses of DLK1 expression in relation to testis histology and total LC number. In the hormone analysis, only results obtained from the area representing the primary histology of the testis (as assessed by several biopsies) were included.
Hormone analysis
Serum levels of reproductive hormones (testosterone, follicle stimulating hormone (FSH), LH, inhibin B, and estradiol) and tumour marker (hCG) were retrieved from the patient records. All samples were analysed in two certified laboratories at Rigshospitalet. Testosterone levels were measured with the DPC Coat-A-Count radioimmunoassay kit (Diagnostic Products, CA, USA) with a detection limit of 0.23 nmol/l and the intra-and inter-assay coefficients of variation (CV) were 7.6% and 8.6%, respectively. Serum FSH and LH were measured by time-resolved immunofluorometric assays (Delfia; Perkin Elmer, MA, USA) with detection limits of 0.06 and 0.05 IU/ l, respectively, and intra-and inter-assay CVs ,5% for both gonadotrophins. Inhibin B was determined in serum by a double antibody immunometric assay (Serotec, UK), with a detection limit of 20 pg/ml and intra-and inter-assay CVs of ,16%. Serum estradiol was measured using a radioimmunoassay (Pantex, CA, USA), with a detection limit of 18 pmol/l and intra-and interassay CVs of ,8 and 13%, respectively. Serum hCG was measured using a microparticle enzyme immunoassay (Abott Diagnostic, IL, USA) with a detection limit of 2 IU/l and intra-and inter-assay CVs of 5.2 and 10%, respectively, or by a sandwich electrochemiluminescense immunoassay (Roche, Switzerland) with a detection limit of 2 IU/l and intra-and inter-assay CVs of 7 and 9%, respectively.
Statistical analysis
The gene expression data were statistically evaluated by the unpaired Student's t-test using the Microsoft Excel software. For all other analyses, a gamma test was used for trend analysis between ranked variables, the Mann-Whitney U-test was used for comparisons between independent groups and correlations between continuous variables were done by Spearman's rank correlation test using the SPSS version 19 software.
Results
Developmental expression of DLK1, COUP-TFII, INSL3, CYP11A1 and SMA in the human testis
Protein expression of DLK1, COUP-TFII, INSL3, CYP11A1 and SMA was analysed by IHC in sections of testis samples during development and in normal adult testis ( Fig. 1 and summarized in Fig. 5A ).
Expression during fetal and infantile development
COUP-TFII was the only marker detected in the gonad at GW 7 (data not shown). At GW 8-9, COUP-TFII was continuously expressed in the interstitial cells and a few interstitial cells began to express DLK1, while CYP11A1 and INSL3 were both negative ( Fig. 1A1 -4) . At GW 10, the earliest fetal LCs with polygonal shape and relative large nuclei and cytoplasm were recognized, all expressing DLK1 and COUP-TFII at high levels. At this time we also observed CYP11A1 and INSL3 expression in a subset of the polygonal LCs and some smaller interstitial cells ( Fig. 1B1-4) . By GW 15, COUP-TFII was completely down-regulated in all fetal LCs, but continuously expressed at high levels in the peritubular and interstitial cells, confirming previous findings (van den Driesche et al., 2012) . At this stage, DLK1 was specifically expressed in the fetal LCs, and CYP11A1 was also expressed in most fetal LCs, whereas INSL3 was only observed in a subset of the fetal LCs (Fig. 1C1 -4) . From GW 11, we observed weakly and sporadically SMA expression in the peritubular cells (Fig. 1C5 ). This expression pattern persisted throughout fetal life and at birth (Fig. 1D1 -5 ).
In the infantile testis (age 2 -3 months), CYP11A1 was the only marker continuously expressed in all LCs. DLK1 expression was markedly decreased and only present in a small subset of plump and elongated spindle-shaped cells; in contrast INSL3 expression was increased and observed in many LCs (Fig. 1E1 -3) . It is of note that the subsets of cells expressing DLK1 or INSL3 rarely overlapped. A heterogeneous expression pattern was observed among samples from infantile testes: DLK1, CYP11A1 and INSL3 were observed in polygonal interstitial cells characteristic of LCs in one sample aged 7 years; DLK1 was abundantly expressed, whereas CYP11A1 and INSL3 were only weakly expressed in a few cells (data not shown). Two additional 7-year-old samples did not contain morphologically recognizable LCs and were negative for DLK1, INSL3 and CYP11A1 (Fig. 1F1-3) . In prepubertal samples from 9-to 10-year-old boys, four out of six samples expressed DLK1 in small cells located in the interstitial space, but at this age no morphological recognizable polygonal or round LCs were observed (Fig. 1G2) . A weak expression of CYP11A1 and INSL3 was also observed in 3 and 2 out of the 4 samples expressing DLK1, respectively. No CYP11A1 and INSL3 expression were observed in the DLK1 negative samples. COUP-TFII was expressed in small interstitial cells in all neonatal and infantile samples (Fig. 1E4, F4, G4 ), but was not expressed in the DLK1-positive cells observed at age 9 -10 years. SMA was continuously low in peritubular cells after birth and throughout infancy, although a few samples showed increased expression with positive cells around most seminiferous tubules (E5, G5, F5 ). Strong SMA expression in vascular tissue was observed at all ages.
Expression in the pubertal and normal adult testis
In pubertal testis samples with established spermatogenesis and in the normal adult testis, the classical LC marker CYP11A1 was expressed in the majority of LCs including polygonal LCs and spindle-shaped progenitor LCs (Fig. 1H1, I1 ). DLK1 expression was observed in a small subset of LCs, predominantly in elongated spindle-shaped cells located adjacent to the peritubular cells of the seminiferous tubules, but also in a few polygonal LCs in the interstitial space (Fig. 1H2, I2 ). INSL3 was expressed in the majority of polygonal LCs (Fig. 1H3, I3 ) and COUP-TFII was expressed in peritubular and mesenchymal stromal cells and in approximately half of the polygonal LCs (Fig. 1H4, I4) . SMA was extensively expressed in peritubular cells in the pubertal and adult testis (Fig. 1H5, I5) .
Expression in adult patients with testicular pathologies
Since DLK1 and INSL3 are expressed in different subsets of LCs during development, we next investigated the presence of the marker panel in different testicular pathologies. Tissue sections of adult testis with various degrees of LC micronodules and testicular dysgenesis, including CIS and SCO/atrophic seminiferous tubules, were analysed at the protein and mRNA levels.
Protein expression of DLK1, CYP11A1, INSL3 and COUP-TFII in LCs
As in the normal testis, CYP11A1 was expressed in the majority of LCs regardless of testicular histology (Fig. 2A1, B1, C1) . In adult testes with LC micronodules (observed in testes with and without the presence of an hGC-producing tumour), an increased proportion of polygonal LCs expressed DLK1 (Fig. 2A2, B2, C2 ). The number of polygonal LCs expressing DLK1 correlated positively with the total number of LCs (correlation coefficient (R): 0.53; P , 0.01) (Fig. 2D ). In line with this observation, the proportion of DLK1-positive polygonal LCs was also greater in tissues with more pronounced signs of testicular dysfunction, with the highest percentage of DLK1-positive cells observed in testes with atrophy of the seminiferous tubules (Fig. 2E) . In some cases with extreme LC hyperplasia, DLK1 was expressed very heterogeneously, being highly positive in some clusters of LCs, but negative in others (Fig. 2C2) . INSL3 was expressed in the majority of LCs in samples with few LC micronodules or diffuse LC hyperplasia (Fig. 2A3) . However, in some samples, often from patients with an hCG-producing tumour, a very heterogeneous pattern of INSL3 expression was observed, with both highly positive and negative cells located next to each other expression patterns in adult testis samples with LC micronodules (A), LC micronodules in TGCT patients with detectable serum hCG (B), and very large LC nodules in testes with severe dysgenesis (C). Note the CYP11A1 expression in all LCs (A1, B1, C1), the higher portion of DLK1+ LCs in LC micronodules (A2, B2, for comparison with normal testis see Fig. 1 I2) , and the mutually exclusive expression of DLK1 and INSL3 in very large LC nodules (C2, C3). Bars correspond to 50 mm in (A and B), and to 100 mm in (C). (D) The correlation between DLK1+ and total number of LCs. (E) The percentage of DLK1+ LCs in normal testis (Control) and in testes with spermatogenesis, CIS or atrophy of the seminiferous tubules from patients with TGCTs (*P , 0.05, **P , 0.01). (F and G) The expression levels of DLK1, INSL3 and CYP11A1 mRNA transcripts shown normalized to B2M for loading control (F) and CYP11A1 for LC cellularity (G) and presented as relative values compared with the value in the samples with normal LCs. Error bars indicate the standard error of the mean. (H and I) The proportion of DLK1+ round or polygonal LCs in relation to serum LH (H) and FSH (I) levels in samples with undetectable serum hCG. Two clusters of samples were observed: one cluster included samples with preserved seminiferous tubules and/or CIS (dots) that were positively correlated to LH and FSH except one 'outlier' with an unexplainable high percentage of DLK1+ LCs; the other included samples with severe atrophy in the whole testis or locally in the section investigated (diamonds). TGCT, testicular germ cell tumor. (Fig. 2B3) . In the samples with extreme LC hyperplasia, several LC clusters were INSL3 negative. In such samples, the cellular expression patterns of DLK1 and INSL3 seemed mutually exclusive (Fig. 2C2-3) . Like in the normal testis, COUP-TFII expression in the dysfunctional testes was observed in the peritubular cells, the mesenchymal stromal cells and in around half of the polygonal LCs (Fig. 2A4, B4 ). To investigate possible differences in proliferation between DLK1-and INSL3-positive LCs, we evaluated the expression of these markers and the proliferation marker KI-67 in serial sections in a separate experiment. We observed very few KI-67-positive LCs, and these were observed in both DLK1 and INLS3 positive cells; however in one sample with large LC clusters, there may be a modest overrepresentation of KI-67 positive cells in the DLK1-positive LC clusters (Supplementary data, Fig. S1 ).
mRNA expression of DLK1, INSL3 and CYP11A1
At the transcriptional level, there was a trend of increased expression of CYP11A1 and DLK1 mRNA in samples with LC micronodules (Fig. 2F) . There was also a trend of increased INSL3 mRNA expression in samples with LC micronodules from patients with undetectable hCG, whereas INSL3 mRNA levels seemed decreased in samples from patients with high serum hCG. Similar expression patterns of DLK1 and INSL3 were observed when normalized to CYP11A1 to account for differences in LC cellularity (Fig. 2G) . But none of these trends were statistically significant. Of note, we did observe a very high variation in transcript levels between individual samples within the specified categories.
DLK1 expression in LCs in relation to reproductive hormone levels in serum
The percentage of round and polygonal LCs expressing DLK1 was correlated to reproductive hormone levels. Only samples from patients with undetectable serum hCG were included in the analysis. For patients with a mixed pattern of normal spermatogenesis, CIS or atrophy, we only included the LC counts from the area of the section that was representative of the primary histology of the whole testis in the analysis.
The proportion of DLK1-positive LCs did not correlate with any hormones when all samples were analysed together. However, with regard to the correlations with the gonadotrophins and inhibin B, the samples of testis tissue from CIS or TGCT patients could be separated into two distinct groups: the majority of the samples, all with ongoing spermatogenesis or CIS, were positively and significantly correlated with LH (R: 0.78; P , 0.01), FSH (R: 0.78; P , 0.01), and Inhibin B (R: 20.74; P , 0.05), and a small group of 'outliers' that had a very high percentage of DLK1-positive LCs independent of LH, FSH and Inhibin B levels (Fig. 2H, 2I , (Inhibin B not shown) and Table IV ). Testicular morphology in all but one of the 'outliers' showed severe atrophy of the seminiferous tubules in the whole testis or locally in the section investigated. Adjacent tumour tissue from two of these samples was examined for hCG-positive cells by IHC, to detect a possible local production of hCG not measurable in serum, but no such cells were found. Unfortunately, the tumour from the 'outlier' with spermatogenesis was too small to allow additional experiments.
Expression in patients with Klinefelter syndrome
In testicular samples from pubertal and adult Klinefelter patients, the mutually exclusive expression pattern of DLK1 and INSL3 was very distinct, with areas of the very large clusters of LCs expressing either DLK1 or INSL3, whereas CYP11A1 was expressed in all LCs, although with varying intensity (Fig. 3A -C) . COUP-TFII was not analysed in testes from these patients due to antibody incompatibility with the fixative of these samples.
Expression in the peritubular compartments
DLK1 protein was not expressed in the peritubular compartment with normal morphology, except in the adjacent spindle-shaped progenitor cells described above, which did not express SMA (Fig. 4A2 -3) . However, in testes with enlargement of the peritubular layers, which is often observed in testes with decreased spermatogenesis, CIS and SCO, DLK1 was extensively expressed in the peritubular compartment. DLK1 was specifically observed in the outer fibroblastic layers and not expressed in the mature peritubular myoid (PTM) cells identified as SMA-positive cells, which were predominantly located in the inner layers of the thickened tubular wall (Fig. 4B2-3 ). DLK1 expression in the peritubular compartment was significantly associated with the thickness of the peritubular layers (P , 0.001) (Fig. 4D) , which also correlated with DLK1 expression in the LC compartment (P , 0.01) (Fig. 4E) .
At the mRNA level, DLK1 seemed increased and INSL3 seemed decreased in samples with atrophy of the seminiferous tubules and thickening of the peritubular layers; however, the findings were not significant. In regard to CYP11A1 expression, there was a significant decrease in mRNA levels in atrophic testis (Fig. 4F) .
In rare samples, cells with morphological characteristics of LCs appeared inside the seminiferous tubules. These ectopic LCs were SMAnegative and often DLK1-positive, but in contrast to other DLK1-positive T, testosterone; E, estradiol; InhB, inhibin B. *P , 0.05, **P , 0.01. cells within the peritubular layers, these cells also expressed additional LC markers such as CYP11A1 (Fig. 4C1-3) . Particularly in testes with LC micronodules, CIS, SCO or atrophy of the seminiferous tubules, DLK1 was also abundantly expressed in smaller interstitial cells. These were either scattered around the interstitial space, or located along the vascular epithelial cells and the LCs. In these samples, DLK1 was also detected in the extracellular matrix in the interstitial space ( Fig. 4B2 and G) .
Discussion
In this study, we investigated the developmental expression patterns of selected markers of Leydig and peritubular cell differentiation and maturation in the human testis (summarized in Fig. 5A ), as well as in adult conditions associated with testicular failure, including Klinefelter syndrome and disorders comprised by the TDS hypothesis. Of particular interest, we found that DLK1, which in the normal adult testis predominantly localizes to spindle-shaped progenitor cells, was up-regulated in testes from patients with signs of testicular dysgenesis, which included a higher proportion of DLK1-positive LCs and of DLK1-positive cells in the outer peritubular compartment. While CYP11A1 was expressed in all LCs, DLK1 and INSL3 proteins were localized to distinct subpopulations of LCs and thus likely defined different stages of differentiation (Fig. 5B) .
We observed DLK1 expression in fetal LCs and a subset of adult LCs, confirming previously published results (Jensen et al., 1999) . In this study, we identified the DLK1-positive subset of adult LCs as progenitor and immature LCs based on the following observations. First, in the normal adult testis DLK1 was predominantly expressed in spindle-shaped cells located adjacent to the peritubular membranes, which is characteristic of progenitor LCs (Chen et al., 2010) . Secondly, the expression of DLK1 and INSL3, a well-known marker for mature LCs (Ivell et al., 2013) , was often mutually exclusive. We also observed that the expression patterns of the two markers over time were inversely associated: DLK1 was abundantly expressed in fetal LCs but rarely present in mature adult LCs and the opposite was true for INSL3 expression. The scarce INSL3 expression in human fetal LCs differs from what has previously been observed in rodents, where INSL3 was extensively expressed in the fetal gonad (Spiess et al., 1999; McKinnell et al., 2005) , suggesting species differences in fetal INSL3 expression. Thirdly, the timing of DLK1 expression seemed to precede the expression of CYP11A1 and INSL3 in the early fetal gonad just prior to the emergence of polygonal fetal LCs, and in the prepubertal testis prior to the emergence of adult LCs, although this observation should be interpreted with caution due to the small sample size at these ages and the relatively poor quality of infantile samples. In both fetal and prepubertal testes, DLK1 was first observed in a population of small interstitial cells, which we propose as the early progenitor LCs. The transition of these cells to morphologically recognizable round or polygonal LCs happened between GW 8 and 10 in the fetal testis. The timing of this transition could not be established in the prepubertal testis, because normal testicular samples from boys of this age are difficult to obtain. Furthermore, many samples would be needed, because there is a large interindividual variation in the onset of normal puberty (Parent et al., 2003; Sørensen et al., 2010) .
The timing and spatial expression of DLK1 is consistent with a role of DLK1 in cell-fate decision. We hypothesize that DLK1 is one of the first factors to be up-regulated in newly recruited LCs and possibly involved in the transition of progenitor LCs into immature LCs. DLK1 appears to be expressed in a relatively small temporal window as a marker for commitment of the cells to differentiate to LCs and maybe also to peritubular cells, but DLK1 is down-regulated when the cells mature. This scenario is comparable to expression patterns of DLK1 established in some other organs; for instance, DLK1 is transiently expressed in myoblasts undergoing differentiation (Waddell et al., 2010; Surmacz et al., 2011) and in b-cells in the pancreas, just before they fully mature (Friedrichsen et al., 2003) . In progenitor neural cells of the brain, DLK1 seems to induce terminal differentiation by antagonising Notch signalling (Surmacz et al., 2011) . A similar function of DLK1 as a Notch repressor in LCs is plausible, since Notch signalling has been suggested to play a pivotal role in LC differentiation by maintaining the LCs in a progenitor state. Down-regulation of Notch signalling is necessary for the final maturation of fetal LCs (Tang et al., 2008) . However, further investigations of this pathway in the human testis are needed to confirm a functional relationship.
In patients with testicular cancer and Klinefelter syndrome, a higher proportion of the polygonal LCs expressed DLK1, and the proportion of DLK1-positive LCs correlated positively with total LC numbers, but without a direct association between DLK 1 expression and cell proliferation. This implies that some LCs in LC micronodules are immature LCs, either arrested in differentiation or recently recruited from the progenitor cells. The latter is possibly the case in the testes with an hCG-producing tumour, which contained the highest percentage of DLK1-positive polygonal LCs. Gonadotrophin levels were also positively correlated with the percentage of DLK1-positive LCs in specimens from patients without hCG-producing tumours, implying a role of DLK1 in the centrally mediated stimulation of LC growth and renewal. DLK1 expression in polygonal LCs in atrophic testes seemed high and independent of gonadotrophin levels, suggesting that the regulation of DLK1 in severe testicular failure may have changed. Alternatively, it is likely that the cells did not differentiate to fully mature testosterone-producing LCs, considering the relatively low testosterone levels in these patients. A limitation of the study is the lack of true stereology in the counting of total and DLK1-positive LCs, which would have increased the confidence of these estimates.
Based on the developmental expression patterns and the mutually exclusive expression of DLK1 and INSL3, we believe that DLK1 and INSL3 define immature and mature LCs, respectively. Impaired INSL3 expression has previously been reported in human testicular samples with LC hyperplasia and adenomas (Klonisch et al., 1999) . In testes with almost complete loss of germ cells and tubular structures, as seen in adult patients with Klinefelter syndrome, the LCs adjacent to the remaining seminiferous tubules containing peritubular and Sertoli cells were most likely to express INSL3, whereas the more distant LCs expressed DLK1. Based on this observation and the concurrent developmental expression profiles of INSL3 and SMA, we hypothesize that paracrine signalling from cells in the seminiferous tubules is required for the terminal transition of immature LCs to fully mature adult LCs. This is in line with animal studies demonstrating the need for Sertoli cell derived factors such as desert hedgehog (DHH) in normal LC differentiation, at least in the fetal testis (Yao et al., 2002) . Also it has been shown that AR signalling in Sertoli cells may regulate LC numbers (De Gendt et al., 2005) , whereas AR signalling in peritubular cells seemed to affect LC function (Welsh et al., 2009) . Interestingly two different compartments of LCs were observed in peritubular cell-specific AR knockout mice; one consisting of INSL3-positive 'normal' LCs, and one consisting of immature LCs with high levels of cytoplasmic lipids and reduced INSL3 expression (Welsh et al., 2012) . This resembles the heterogeneity in the LC population often observed in humans with LC micronodules.
Interestingly, in samples with thickening of the peritubular layers, which is often seen in testes with poor spermatogenesis, DLK1 was also expressed in the peritubular and perivascular compartments. The expression in the peritubular compartment was specifically observed in the outer layers of low-differentiated fibroblasts, and not in the inner layers of SMA-positive mature peritubular myoid cells. The progenitor characteristics of these cells were emphasized previously by the expression of the haematopoietic stem cell marker CD34 (Volkmann et al., 2011) , and supported by the high DLK1 expression in these cells observed in this study. This layer is barely detectable in the normal testis, but highly enlarged in dysfunctional testes. The enlargement is mainly due to an increase in the outer layer of mesenchymal fibroblast-like cells and the accumulation of extracellular matrix, whereas the thickness of the SMA-positive layer of mature peritubular myoid cells remains relatively unchanged (Volkmann et al., 2011; Adam et al., 2012) .
Though it is still speculative, it is plausible that progenitor cells of both peritubular myoid and LCs are recruited from stem cells located in the outer peritubular membranes. The rare findings of ectopic LCs inside the peritubular wall may support the presence of progenitor LCs within this compartment. It is possible that the ectopic LCs arise because of disruption of normal cell signalling within its developing niche. At least the presence of ectopic fetal LCs is increased in rodents with testicular dysgenesis induced by di-butyl phthalate (DBP) exposure .
We also investigated COUP-TFII in human orchidectomy samples. COUP-TFII was expressed in approximately half of the adult polygonal LCs, but without any apparent association with a type of pathology. Our study confirmed the fetal expression pattern previously reported in rodents and humans (Qin et al., 2008; van den Driesche et al., 2012) , defining COUP-TFII as a general marker of mesenchymal and peritubular cells, and of early fetal LCs, the appearance of which in the humans corresponds to the differentiation phase of fetal LC development (Pelliniemi and Niemi, 1969) .
Taken together, in this study, we demonstrated an impairment of proper differentiation and function of interstitial cells in patients with testicular failure, including disorders comprised by the TDS hypothesis and Klinefelter syndrome, with marked cellular heterogeneity due to the presence of cells at different stages in differentiation. We established the developmental expression patterns of key differentiation markers, which may be clinically useful in defining the stage of LC maturation in adult patients, with DLK1 identified as a marker of progenitor and immature LCs. The increased expression of DLK1 in testes with LC micronodules may be consistent with true hyperplasia and LC recruitment as a consequence of increased gonadotrophin levels, but it may also be the result of poor development of LCs, which is likely a pathogenic factor in testicular dysgenesis. 
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